Campochiaro, Peter A. http://orcid.org/0000-0003-2531-8229
Article History
Received: 5 May 2023
Revised: 9 May 2023
Accepted: 17 May 2023
First Online: 5 June 2023
Competing interests
: Consultant: Aerpio, Allegro Ophthalmics, AsclepiX, Ashvattha, Bausch + Lomb, Catawba Research, Celanese, Clearside Biomedical, Cove, CureVac, Exegenesis Bio, Exonate, Graybug, Merck, Novartis, Perfuse, Wave Life Sciences; Financial support—Aerpio, Ashvattha, Genentech, Inc./Roche, Graybug, Mallinckrodt, Oxford Biomedica, Regeneron, Regenixbio, Sanofi Genzyme. Consultant for which institution receives payment: Genentech, Inc./Roche. Stock Options: Allegro Ophthalmics, Cove.
Free to read: This content has been made available to all.